全文获取类型
收费全文 | 1209篇 |
免费 | 89篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 15篇 |
妇产科学 | 20篇 |
基础医学 | 217篇 |
口腔科学 | 11篇 |
临床医学 | 124篇 |
内科学 | 262篇 |
皮肤病学 | 11篇 |
神经病学 | 127篇 |
特种医学 | 26篇 |
外国民族医学 | 22篇 |
外科学 | 129篇 |
综合类 | 8篇 |
一般理论 | 1篇 |
预防医学 | 79篇 |
眼科学 | 20篇 |
药学 | 104篇 |
中国医学 | 10篇 |
肿瘤学 | 115篇 |
出版年
2023年 | 10篇 |
2022年 | 39篇 |
2021年 | 51篇 |
2020年 | 18篇 |
2019年 | 35篇 |
2018年 | 48篇 |
2017年 | 25篇 |
2016年 | 35篇 |
2015年 | 37篇 |
2014年 | 47篇 |
2013年 | 48篇 |
2012年 | 84篇 |
2011年 | 81篇 |
2010年 | 44篇 |
2009年 | 43篇 |
2008年 | 79篇 |
2007年 | 89篇 |
2006年 | 76篇 |
2005年 | 60篇 |
2004年 | 70篇 |
2003年 | 72篇 |
2002年 | 77篇 |
2001年 | 19篇 |
2000年 | 15篇 |
1999年 | 15篇 |
1998年 | 7篇 |
1997年 | 9篇 |
1996年 | 9篇 |
1995年 | 7篇 |
1993年 | 4篇 |
1992年 | 5篇 |
1991年 | 2篇 |
1990年 | 5篇 |
1987年 | 1篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1982年 | 3篇 |
1981年 | 1篇 |
1980年 | 3篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1974年 | 2篇 |
1972年 | 3篇 |
1971年 | 2篇 |
1970年 | 3篇 |
1969年 | 3篇 |
1968年 | 3篇 |
1967年 | 3篇 |
1966年 | 6篇 |
1965年 | 1篇 |
排序方式: 共有1306条查询结果,搜索用时 31 毫秒
41.
42.
43.
44.
Evidence of the immunomodulatory role of dual PI3K/mTOR inhibitors in transplantation: an experimental study in mice 下载免费PDF全文
Valery Vilchez Lilia Turcios David A. Butterfield Mihail I. Mitov Cristin L. Coquillard Ja Anthony Brandon Virgilius Cornea Roberto Gedaly Francesc Marti 《Transplant international》2017,30(10):1061-1074
The PI3K/mTOR signaling cascade is fundamental in T‐cell activation and fate decisions. We showed the distinct regulation of PI3K/mTOR in regulatory and effector T‐cells and proposed the potential therapeutic benefit of targeting this pathway to control the balance between effector and regulatory T‐cell activities. Substantial adverse effects in long‐term clinical usage of rapamycin suggest the use of alternative treatments in restraining effector T‐cell function in transplant patients. We hypothesize that dual PI3K/mTOR inhibitors may represent an immunosuppressant alternative. Here we show that dual PI3K/mTOR PI‐103 and PKI‐587 inhibitors interfered IL‐2‐dependent responses in T‐cells. However, in contrast to the inhibitory effects in non‐Treg T‐cell proliferation and effector functions, dual inhibitors increased the differentiation, preferential expansion, and suppressor activity of iTregs. Rapamycin, PI‐103, and PKI‐587 targeted different signaling events and induced different metabolic patterns in primary T‐cells. Similar to rapamycin, in vivo administration of PI‐103 and PKI‐587 controlled effectively the immunological response against allogeneic skin graft. These results characterize specific regulatory mechanisms of dual PI3K/mTOR inhibitors in T‐cells and support their potential as a novel therapeutic option in transplantation. 相似文献
45.
46.
Valery Leytin Asuman Mutlu Sergiy Mykhaylov David J. Allen Armen V. Gyulkhandanyan John Freedman 《Haematologica》2009,94(12):1783-1784
47.
Olga V. Chumakova Anton V. Liopo Valery G. Andreev Inga Cicenaite B. Mark Evers Shilla Chakrabarty Todd C. Pappas Rinat O. Esenaliev 《Cancer letters》2008
The goal of this study was to enhance gene delivery and tumor cell transfection in vivo by using a combination of ultrasonication with complex nanoparticles consisting of two types of nanoparticles: PEI/DNA β-gal plasmid with highly positive zeta-potential and air-filled poly (lactic-co-glycolic acid) (PLGA) particles (with negative zeta-potential) manufactured in our laboratory. The PLGA/PEI/DNA nanoparticles were a colloid with positive zeta-potential and injected i.v. in nude mice with DU145 human prostate tumors. We found that the combination of PLGA/PEI/DNA nanoparticles with ultrasonication substantially enhanced tumor cell transfection in vivo. The overexpression of β-gal gene was evaluated histochemically and by Western blot analysis. At least an 8-fold increase of the cell transfection efficacy was obtained in irradiated tumors compared to non-irradiated controls, while little to no cell death was produced by ultrasonication. 相似文献
48.
Kreuter J Shamenkov D Petrov V Ramge P Cychutek K Koch-Brandt C Alyautdin R 《Journal of drug targeting》2002,10(4):317-325
Recent studies have shown that drugs that are normally unable to cross the blood-brain barrier (BBB) following intravenous injection can be transported across this barrier by binding to poly(butyl cyanoacrylate) nanoparticles and coating with polysorbate 80. However, the mechanism of this transport so far was not known. In the present paper, the possible involvement of apolipoproteins in the transport of nanoparticle-bound drugs into the brain is investigated. Poly(butyl cyanoacrylate) nanoparticles loaded with the hexapeptide dalargin were coated with the apolipoproteins AII, B, CII, E, or J without or after precoating with polysorbate 80. In addition, loperamide-loaded nanoparticles were coated with apolipoprotein E alone or again after precoating with polysorbate 80. After intravenous injection to ICR mice the antinociceptive threshold was measured by the tail flick test. Furthermore, the antinociceptive threshold of polysorbate 80-coated dalargin-loaded nanoparticles was determined in ApoEtm1Unc and C57BL/6J mice. The results show that only dalargin or loperamide-loaded nanoparticles coated with polysorbate 80 and/or with apolipoprotein B or E were able to achieve an antinociceptive effect. This effect was significantly higher after polysorbate-precoating and apolipoprotein B or E-overcoating. With the apolipoprotein E-deficient ApoEtm1Unc mice the antinociceptive effect was considerably reduced in comparison to the C57BL/6J mice. These results suggest that apolipoproteins B and E are involved in the mediation of the transport of drugs bound to poly(butyl cyanoacrylate) nanoparticles across the BBB. Polysorbate 80-coated nanoparticles adsorb these apolipoproteins from the blood after injection and thus seem to mimic lipoprotein particles that could be taken up by the brain capillary endothelial cells via receptor-mediated endocytosis. Bound drugs then may be further transported into the brain by diffusion following release within the endothelial cells or, alternatively, by transcytosis. 相似文献
49.
The oxazole derivative, irampanel, a non-competitive AMPA receptor antagonist, is under development by Boehringer Ingelheim for the potential treatment of stroke [329079]. Phase I/IIa trials for stroke had been initiated by July 2000 [374144]. Phase II trials were ongoing in April 2001 [407163]; in April 2002, however, the drug did not appear on the company's research and development pipeline [446554], and a company spokesperson declined to confirm its current status [450591]. The compound was also originally under investigation for other neurological disorders, including epilepsy and pain [329079], although by October 1999, development was only ongoing for stroke [346080]. 相似文献
50.
Evolution of genomic diversity and sex at extreme environments: fungal life under hypersaline Dead Sea stress 下载免费PDF全文
Kis-Papo T Kirzhner V Wasser SP Nevo E 《Proceedings of the National Academy of Sciences of the United States of America》2003,100(25):14970-14975
We have found that genomic diversity is generally positively correlated with abiotic and biotic stress levels (1-3). However, beyond a high-threshold level of stress, the diversity declines to a few adapted genotypes. The Dead Sea is the harshest planetary hypersaline environment (340 g.liter-1 total dissolved salts, approximately 10 times sea water). Hence, the Dead Sea is an excellent natural laboratory for testing the "rise and fall" pattern of genetic diversity with stress proposed in this article. Here, we examined genomic diversity of the ascomycete fungus Aspergillus versicolor from saline, nonsaline, and hypersaline Dead Sea environments. We screened the coding and noncoding genomes of A. versicolor isolates by using >600 AFLP (amplified fragment length polymorphism) markers (equal to loci). Genomic diversity was positively correlated with stress, culminating in the Dead Sea surface but dropped drastically in 50- to 280-m-deep seawater. The genomic diversity pattern paralleled the pattern of sexual reproduction of fungal species across the same southward gradient of increasing stress in Israel. This parallel may suggest that diversity and sex are intertwined intimately according to the rise and fall pattern and adaptively selected by natural selection in fungal genome evolution. Future large-scale verification in micromycetes will define further the trajectories of diversity and sex in the rise and fall pattern. 相似文献